In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

MicroPort Scientific floats on the Hong Kong Stock Exchange

Executive Summary

MicroPort Scientific Corp. (primarily cardiovascular medical devices) has raised HK$1.54bn ($199.7mm) through the initial public offering of 252.7mm new shares (18% of the company) for HK$6.10 each on the Hong Kong Stock Exchange. Unlike other companies experiencing trying times while attempting to float, MicroPort avoided a haircut and raised the amount it originally sought. (The company had planned to sell the shares between HK$4.60-6.10 each.)
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies